All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...

Panelists explain that KMT2A-rearranged acute myeloid leukemia (AML) is a biologically aggressive and diagnostically complex leukemia subtype—especially prevalent in pediatric and therapy-related ...

HGTV head of content Loren Ruch, who was also the co-host of HGTV’s House Party, died last Thursday (June 12). He was 55 ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

This single-arm, multicenter Phase II study assessed the efficacy and safety of olverembatinib in combination with the VP (vindesine+prednisone) regimen (OVP) in the first-line treatment of adult ...

Rates of grade III/IV acute GVHD at 3 months were 3% with cyclophosphamide-cyclosporin prophylaxis and 10% with standard prophylaxis, reported David Curtis, MBBS, PhD, of Alfred H ...